Globus Medical, Inc.
GMED
$58.74
-$0.88-1.48%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.63B | 2.51B | 2.52B | 2.48B | 2.24B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.63B | 2.51B | 2.52B | 2.48B | 2.24B |
| Cost of Revenue | 864.01M | 881.28M | 873.61M | 870.39M | 796.00M |
| Gross Profit | 1.76B | 1.63B | 1.65B | 1.61B | 1.44B |
| SG&A Expenses | 1.04B | 976.02M | 978.78M | 970.10M | 885.82M |
| Depreciation & Amortization | 118.98M | 118.50M | 119.37M | 117.58M | 101.27M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.16B | 2.11B | 2.13B | 2.14B | 1.96B |
| Operating Income | 462.52M | 396.21M | 386.00M | 340.01M | 278.41M |
| Income Before Tax | 373.54M | 232.95M | 120.72M | 121.05M | 66.55M |
| Income Tax Expenses | 16.89M | 47.39M | 17.74M | 29.54M | 25.88M |
| Earnings from Continuing Operations | 356.65 | 185.56 | 102.98 | 91.51 | 40.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 356.65M | 185.56M | 102.98M | 91.51M | 40.68M |
| EBIT | 462.52M | 396.21M | 386.00M | 340.01M | 278.41M |
| EBITDA | 734.51M | 661.33M | 640.37M | 597.32M | 506.16M |
| EPS Basic | 2.63 | 1.36 | 0.76 | 0.67 | 0.30 |
| Normalized Basic EPS | 2.04 | 1.71 | 1.57 | 1.59 | 1.32 |
| EPS Diluted | 2.60 | 1.34 | 0.75 | 0.66 | 0.29 |
| Normalized Diluted EPS | 2.00 | 1.68 | 1.54 | 1.57 | 1.31 |
| Average Basic Shares Outstanding | 544.31M | 544.30M | 542.90M | 544.05M | 521.97M |
| Average Diluted Shares Outstanding | 554.05M | 554.53M | 550.11M | 549.42M | 526.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |